CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for liver diseases and infection, is pleased to announce the commencement of a research collaboration with Alnylam Pharmaceuticals. Research relevant to the advancement of Alnylam’s RNAi therapeutics will be performed using CN Bio’s human liver-on-a-chip platform, LiverChip.

This deal follows announcements earlier in 2015 of collaborations with Benitec BioPharma, Isis Pharmaceuticals and a number of global pharmaceutical companies, demonstrating strong interest from the industry in CN Bio’s LiverChip platform and Hepatitis B disease model Quantum-B®.

Dr Emma Sceats, CN Bio’s Chief Operating Officer, said “After years of hype surrounding organ-on-chip technologies the reality in 2015 is that a highly complex organ like the liver can be built in the laboratory and used to advance our understanding of various disease and infections. We are excited to be applying these technologies in programs with several pharmaceutical partners and expect new insights into novel therapeutic approaches will arise from these collaborations.”

Read the full press release here.

← Back To All News


We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

Update!

CN Bio has capped a busy and successful year off by moving offices to the Cambridge Science Park where we have moved to larger purpose-fitted facilities.

Please update your records with our new contact information.

New Street Address & Mailing Address
332 Cambridge Science Park
Milton Road
Cambridge
CB4 0WN

Tel: 01223 737941

Wishing you, your family and colleagues a very Happy Holiday season from all of the team at CN Bio.